Rhumbline Advisers Lowers Stake in American Healthcare REIT, Inc. (NYSE:AHR)

Rhumbline Advisers reduced its position in shares of American Healthcare REIT, Inc. (NYSE:AHR) by 2.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 249,975 shares of the company’s stock after selling 6,318 shares during the quarter. Rhumbline Advisers owned 0.16% of American Healthcare REIT worth $7,574,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of AHR. Janney Montgomery Scott LLC boosted its stake in shares of American Healthcare REIT by 4.0% during the 4th quarter. Janney Montgomery Scott LLC now owns 13,915 shares of the company’s stock worth $395,000 after acquiring an additional 533 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of American Healthcare REIT by 67.0% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,236 shares of the company’s stock worth $121,000 after acquiring an additional 1,699 shares in the last quarter. State of Alaska Department of Revenue boosted its stake in shares of American Healthcare REIT by 101.2% during the 4th quarter. State of Alaska Department of Revenue now owns 72,799 shares of the company’s stock worth $2,068,000 after acquiring an additional 36,625 shares in the last quarter. Strategic Financial Concepts LLC acquired a new position in shares of American Healthcare REIT during the 4th quarter worth about $331,000. Finally, Sumitomo Mitsui DS Asset Management Company Ltd raised its position in shares of American Healthcare REIT by 15.3% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 30,895 shares of the company’s stock worth $878,000 after purchasing an additional 4,090 shares during the last quarter. 16.68% of the stock is owned by hedge funds and other institutional investors.

American Healthcare REIT Stock Up 0.0%

AHR stock opened at $35.21 on Wednesday. The company has a market cap of $5.62 billion, a price-to-earnings ratio of -73.35, a PEG ratio of 1.57 and a beta of 1.21. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.59. American Healthcare REIT, Inc. has a 12 month low of $14.32 and a 12 month high of $36.00. The firm has a 50-day moving average of $32.44 and a two-hundred day moving average of $30.05.

American Healthcare REIT (NYSE:AHR) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. The company had revenue of $540.60 million during the quarter, compared to the consensus estimate of $542.32 million. American Healthcare REIT had a negative net margin of 1.84% and a negative return on equity of 1.87%. American Healthcare REIT’s quarterly revenue was up 8.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.30 EPS. As a group, analysts forecast that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current fiscal year.

American Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, April 17th. Stockholders of record on Monday, March 31st were paid a $0.25 dividend. The ex-dividend date was Monday, March 31st. This represents a $1.00 annualized dividend and a dividend yield of 2.84%. American Healthcare REIT’s dividend payout ratio (DPR) is -370.37%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on AHR. JMP Securities set a $35.00 price target on shares of American Healthcare REIT in a research report on Tuesday, March 4th. KeyCorp reduced their price target on shares of American Healthcare REIT from $35.00 to $34.00 and set an “overweight” rating for the company in a research report on Monday, March 31st. Truist Financial upped their price target on shares of American Healthcare REIT from $32.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday. Royal Bank of Canada restated an “outperform” rating and set a $34.00 price target on shares of American Healthcare REIT in a research report on Wednesday, March 19th. Finally, Morgan Stanley upped their price target on shares of American Healthcare REIT from $37.00 to $45.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 20th. Eight investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $36.29.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.